Mott David M

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Mott David M
CIK #0001219871
EDGAR Form CIK 2011 - 2026
3 [0001219871]
4 [0001219871]
Form 3/4/5 Subject 2011 - 2026
Novavax Inc
Mott David M
Ardelyx Inc
Mersana Therapeutics Inc
Adaptimmune Therapeutics PLC
Epizyme Inc
Enliven Therapeutics Inc
Kerins Patrick J
NEA Partners 14 LP
New Enterprise Associates 14 LP
Baskett Forest
Casper Sleep Inc
NEA 14 GP Ltd
Sonsini Peter W
Sandell Scott D
Black Diamond Therapeutics Inc
Regulus Therapeutics Inc
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
New Enterprise Associates 13 LP
Sprout Social Inc
Galera Therapeutics Inc
Barris Peter J
Florence Anthony A Jr
Oyster Point Pharma Inc
Cloudflare Inc
Mirum Pharmaceuticals Inc
Genocea Biosciences Inc
Nightstar Therapeutics PLC
Trevi Therapeutics Inc
Aveo Pharmaceuticals Inc
Tesaro Inc
Ra Pharmaceuticals Inc
Tempest Therapeutics Inc
Viswanathan Ravi
Barrett M James
PhaseBio Pharmaceuticals Inc
Marker Therapeutics Inc
Elastic NV
Mulesoft Inc
Surface Oncology Inc
Tracon Pharmaceuticals Inc
Cascadian Therapeutics Inc
Oruka Therapeutics Inc
Appian Corp
Synlogic Inc
Strongbridge Biopharma PLC
X4 Pharmaceuticals Inc
Carecom Inc
Rhythm Pharmaceuticals Inc
Achaogen Inc
Sorrento Tech Inc
Interleukin Genetics Inc
Avalo Therapeutics Inc
Champions Oncology Inc
Box Inc
Cvent Inc
Dermira Inc
Loxo Oncology Inc
Aerohive Networks Inc
Weller Harry R
Kolluri Krishna Kittu
Crescent Biopharma Inc
Drant Ryan D
Omthera Pharmaceuticals Inc
Clovis Oncology Inc
Workday Inc
Millennial Media Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ardelyx Inc ARDX
Common Stock
2026-02-20 Buy 333,333 $5.84 1,946,665
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 1,000
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 734
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 368
Mersana Therapeutics Inc MRSN
Common Stock
2026-01-06 Tender 383
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 1,800
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 181
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 2,200
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 740
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 1,011
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 1,002
Mersana Therapeutics Inc MRSN
Common Stock
2026-01-06 Tender 23,546
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 2,460
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 400
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 788
Mersana Therapeutics Inc MRSN
Stock Option (right to buy) · derivative
2026-01-06 Disposed to issuer 264
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
2025-06-20 Grant 28,326 $6.42 181,853
Novavax Inc NVAX
Restricted Stock Units · derivative
2025-06-20 Grant 18,884 $0.00
Ardelyx Inc ARDX
Stock Option (Right to Buy) · derivative
2025-06-18 Grant 54,059 $0.00
Ardelyx Inc ARDX
Common Stock
2025-06-18 Grant 31,163 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com